Evidence map›Paper›PMID 27799336›Full record

ArticleInfection and immunity2017

Borrelia burgdorferi CheY2 Is Dispensable for Chemotaxis or Motility but Crucial for the Infectious Life Cycle of the Spirochete.

Hui Xu, Syed Sultan, Aaron Yerke, Ki Hwan Moon, R Mark Wooten, M A Motaleb

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Chemotaxis Coupling Protein CheWInfection and immunity · 2023
    Article
  9. Article
  10. The Divergent Key Residues of TwoMicroorganisms · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Frontiers in immunology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Hui XuDepartment of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
Syed SultanDepartment of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
Aaron YerkeDepartment of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
Ki Hwan MoonDepartment of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
R Mark WootenDepartment of Medical Microbiology and Immunology, College of Medicine and Life Sciences, University of Toledo, Toledo, Ohio, USA.
M A MotalebDepartment of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA motalebm@ecu.edu.
University of Toledo · USEast Carolina University · USThe University of Texas at Austin · US

Funding

Intravital assessment of Borrelia burgdorferi immune clearance in skinR01AI121970 · NIAID · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI WOOTEN, RONALD MARK · 2016 to 2020
$1.9M
Delineation of Borrelia burgdorferi motility and chemotaxis in the development ofR01AR060834 · NIAMS · EAST CAROLINA UNIVERSITY · PI MOTALEB, MD A · 2011 to 2015
$1.8M
Discovery and characterization of novel flagellar proteins in Borrelia burgdorferiR21AI113014 · NIAID · EAST CAROLINA UNIVERSITY · PI MOTALEB, MD A · 2015 to 2016
$423k
Intravital assessment of Borrelia burgdorferi-immune cell interactions in skinR56AI105128 · NIAID · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI WOOTEN, RONALD MARK · 2014 to 2014
$385k
NIAID NIH HHS R01 AI121970NIAID NIH HHS R21 AI113014NIAID NIH HHS R56 AI105128NIAMS NIH HHS R01 AR060834
6 · The paper itself

Abstract

The requirements for bacterial chemotaxis and motility range from dispensable to crucial for host colonization. Even though more than 50% of all sequenced prokaryotic genomes possess at least one chemotaxis signaling system, many of those genomes contain multiple copies of a chemotaxis gene. However, the functions of most of those additional genes are unknown. Most motile bacteria possess at least one CheY response regulator that is typically dedicated to the control of motility and which is usually essential for virulence. Borrelia burgdorferi appears to be notably different, in that it has three cheY genes, and our current studies on cheY2 suggests that it has varied effects on different aspects of the natural infection cycle. Mutants deficient in this protein exhibit normal motility and chemotaxis in vitro but show reduced virulence in mice. Specifically, the cheY2 mutants were severely attenuated in murine infection and dissemination to distant tissues after needle inoculation. Moreover, while ΔcheY2 spirochetes are able to survive normally in the Ixodes ticks, mice fed upon by the ΔcheY2-infected ticks did not develop a persistent infection in the murine host. Our data suggest that CheY2, despite resembling a typical response regulator, functions distinctively from most other chemotaxis CheY proteins. We propose that CheY2 serves as a regulator for a B. burgdorferi virulence determinant that is required for productive infection within vertebrate, but not tick, hosts.

Indexed as

AnimalsBacterial ProteinsBorrelia burgdorferiChemotaxisIxodesLife Cycle StagesLyme DiseaseMiceMice, Inbred C3HMutationSignal TransductionSpirochaetalesSpirochaetales InfectionsVirulenceVirulence FactorsBacterial ProteinsVirulence FactorsBorrelia burgdorferichemotaxischemotaxis/motilityCheYflagellaLyme diseasepathogenesisresponse regulatorspirochetestick-mousevirulence

Identifiers

PMID27799336
PMCPMC5203640
OpenAlexW2542270484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.